- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/38 - Nitrogen atoms
Patent holdings for IPC class C07D 231/38
Total number of patents in this class: 518
10-year publication summary
|
38
|
30
|
38
|
28
|
38
|
29
|
20
|
36
|
28
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Loxo Oncology, Inc. | 83 |
14 |
| FMC Corporation | 845 |
13 |
| Novartis AG | 10744 |
12 |
| Bayer Cropscience AG | 2040 |
9 |
| Assembly Biosciences, Inc. | 79 |
8 |
| Mereo Biopharma 1 Limited | 25 |
8 |
| Hua Medicine (Shanghai) Ltd. | 59 |
8 |
| Novartis Pharma AG | 96 |
7 |
| E. I. du Pont de Nemours and Company | 4050 |
7 |
| Boehringer Ingelheim International GmbH | 4642 |
7 |
| Bayer Pharma AG | 1053 |
7 |
| Epigen Biosciences, Inc. | 13 |
7 |
| Shionogi & Co., Ltd. | 852 |
7 |
| Nodthera Limited | 39 |
7 |
| Glaxo Group Limited | 4063 |
6 |
| FUJIFILM Corporation | 29437 |
6 |
| The Government of the United States of America, as represented by the Secretary of the Navy | 1303 |
6 |
| Vanderbilt University | 1907 |
6 |
| AstraZeneca AB | 2892 |
5 |
| The Trustees of the University of Pennsylvania | 4323 |
5 |
| Other owners | 363 |